Literature DB >> 4206491

Transport of thyroid hormones in serum and cerebrospinal fluid.

G A Hagen, W J Elliott.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4206491     DOI： 10.1210/jcem-37-3-415

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  23 in total

Review 1.  Brain meets body: the blood-brain barrier as an endocrine interface.

Authors:  William A Banks
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

2.  Inhibition by lead of production and secretion of transthyretin in the choroid plexus: its relation to thyroxine transport at blood-CSF barrier.

Authors:  W Zheng; W S Blaner; Q Zhao
Journal:  Toxicol Appl Pharmacol       Date:  1999-02-15       Impact factor: 4.219

3.  Induction of type 2 iodothyronine deiodinase in the mediobasal hypothalamus by bacterial lipopolysaccharide: role of corticosterone.

Authors:  Edith Sánchez; Praful S Singru; Csaba Fekete; Ronald M Lechan
Journal:  Endocrinology       Date:  2008-01-24       Impact factor: 4.736

4.  From molecular variant to disease: initial steps in evaluating the association of transthyretin M119 with disease.

Authors:  S Ii; J L Sobell; S S Sommer
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

Review 5.  Current and future treatment of amyloid diseases.

Authors:  M Ankarcrona; B Winblad; C Monteiro; C Fearns; E T Powers; J Johansson; G T Westermark; J Presto; B-G Ericzon; J W Kelly
Journal:  J Intern Med       Date:  2016-05-10       Impact factor: 8.989

Review 6.  The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug.

Authors:  Steven M Johnson; Stephen Connelly; Colleen Fearns; Evan T Powers; Jeffery W Kelly
Journal:  J Mol Biol       Date:  2012-01-05       Impact factor: 5.469

7.  The Thyroid Hormone Inactivating Type 3 Deiodinase Is Essential for Optimal Neutrophil Function: Observations From Three Species.

Authors:  Anne H van der Spek; Kin Ki Jim; Aldona Karaczyn; Hermina C van Beeren; Mariëtte T Ackermans; Veerle M Darras; Christina M J E Vandenbroucke-Grauls; Arturo Hernandez; Matthijs C Brouwer; Eric Fliers; Diederik van de Beek; Anita Boelen
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

8.  Delayed development of specific thyroid hormone-regulated events in transthyretin null mice.

Authors:  Julie A Monk; Natalie A Sims; Katarzyna M Dziegielewska; Roy E Weiss; Robert G Ramsay; Samantha J Richardson
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-23       Impact factor: 4.310

9.  Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients.

Authors:  Joseph D Schonhoft; Cecilia Monteiro; Lars Plate; Yvonne S Eisele; John M Kelly; Daniel Boland; Christopher G Parker; Benjamin F Cravatt; Sergio Teruya; Stephen Helmke; Mathew Maurer; John Berk; Yoshiki Sekijima; Marta Novais; Teresa Coelho; Evan T Powers; Jeffery W Kelly
Journal:  Sci Transl Med       Date:  2017-09-13       Impact factor: 17.956

10.  Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors.

Authors:  Teresa Mairal; Joan Nieto; Marta Pinto; Maria Rosário Almeida; Luis Gales; Alfredo Ballesteros; José Barluenga; Juan J Pérez; Jesús T Vázquez; Nuria B Centeno; Maria Joao Saraiva; Ana M Damas; Antoni Planas; Gemma Arsequell; Gregorio Valencia
Journal:  PLoS One       Date:  2009-01-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.